These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Passive immunization as prophylaxis: when and where will this work? Dunman PM; Nesin M Curr Opin Pharmacol; 2003 Oct; 3(5):486-96. PubMed ID: 14559093 [TBL] [Abstract][Full Text] [Related]
3. Passive immunoprophylaxis with human monoclonal antibodies. Masuho Y Biotechnology; 1992; 20():405-30. PubMed ID: 1600386 [No Abstract] [Full Text] [Related]
4. [Immunoglobulins and rules of passive-active prophylaxis]. Bucholc B Przegl Epidemiol; 2003; 57(2):391-7. PubMed ID: 12910611 [TBL] [Abstract][Full Text] [Related]
5. Immunization against infectious disease in adult oncology. Fairlamb DJ Clin Oncol (R Coll Radiol); 1992 May; 4(3):139-40. PubMed ID: 1586630 [No Abstract] [Full Text] [Related]
6. An augmented passive immune therapy to treat fulminant bacterial infections. Rajam G; Sampson J; Carlone GM; Ades EW Recent Pat Antiinfect Drug Discov; 2010 Jun; 5(2):157-67. PubMed ID: 20370679 [TBL] [Abstract][Full Text] [Related]
7. Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Casadevall A Emerg Infect Dis; 2002 Aug; 8(8):833-41. PubMed ID: 12141970 [TBL] [Abstract][Full Text] [Related]
8. Passive immunity in prevention and treatment of infectious diseases. Keller MA; Stiehm ER Clin Microbiol Rev; 2000 Oct; 13(4):602-14. PubMed ID: 11023960 [TBL] [Abstract][Full Text] [Related]
9. Vaccination in pregnancy. Amstey MS Clin Obstet Gynaecol; 1983 Apr; 10(1):13-22. PubMed ID: 6872401 [No Abstract] [Full Text] [Related]
11. Passive immunotherapy of viral infections: 'super-antibodies' enter the fray. Walker LM; Burton DR Nat Rev Immunol; 2018 May; 18(5):297-308. PubMed ID: 29379211 [TBL] [Abstract][Full Text] [Related]
12. [Prevention of infectious complications in burn patients by using an immunoglobulin with normal antitissue antibodies]. Murazian RI; Panchenkov NR; Murashova NS; Kozlova MA Gematol Transfuziol; 1988 May; 33(5):38-41. PubMed ID: 3410266 [No Abstract] [Full Text] [Related]
13. A mechanism of passive immunization with monoclonal antibodies to a 185,000 M(r) streptococcal antigen. Lehner T; Ma JK; Kelly CG Adv Exp Med Biol; 1992; 327():151-63. PubMed ID: 1295336 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human polyclonal antibodies: A new class of therapeutic antibodies against viral infections. Bregenholt S; Jensen A; Lantto J; Hyldig S; Haurum JS Curr Pharm Des; 2006; 12(16):2007-15. PubMed ID: 16787244 [TBL] [Abstract][Full Text] [Related]
15. A summary of the workshop on passive immunization using monoclonal antibodies for HIV/AIDS, held at the National Institute of Allergy and Infectious Diseases, Bethesda, 10 March 2006. Bansal GP Biologicals; 2007 Oct; 35(4):367-71. PubMed ID: 17889555 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of passive immunoprophylaxis in paediatric patients at risk of severe RSV infection. Pons JM; Tebé C; Paladio N; Garcia-Altes A; Danés I; Valls-I-Soler A Acta Paediatr; 2011 Mar; 100(3):324-9. PubMed ID: 20950412 [TBL] [Abstract][Full Text] [Related]